| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $84.5M | +69.0% |
| SG&A Expense | $23.7M | +59.3% |
| Operating Income | -$108.1M | -154.1% |
| Pre-tax Income | -$105.0M | -159.6% |
| Income Tax | $2K | +0.0% |
| Net Income | -$105.0M | -159.6% |
| EPS (Basic) | -$2.26 | -96.5% |
| EPS (Diluted) | -$2.26 | -96.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $287.8M | +2450.3% |
| Current Assets | $322.9M | +97.7% |
| Total Assets | $355.9M | +108.8% |
| Current Liabilities | $35.8M | +70.4% |
| Total Liabilities | $50.2M | +100.5% |
| Stockholders' Equity | $305.8M | +110.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.8M | -74.5% |
| Capital Expenditures | $2.9M | +148.9% |
| Investing Cash Flow | $97.5M | +183.9% |
| Financing Cash Flow | $248.9M | +62.9% |
| Free Cash Flow | -$72.7M | -76.7% |